Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

5

Number of overlapping holdings

16.7%

% of MEDX's 30 holdings also in GDOC

12.2%

% of GDOC's 43 holdings also in MEDX

Overlap by Weight
Sector Drift (MEDX minus GDOC)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in MEDX
Weight
in GDOC
Overlap
ELI LILLY & CO 17.0% 10.4% 10.4%
ABBVIE INC 7.9% 4.7% 4.7%
AMGEN INC 5.9% 4.6% 4.6%
BIOGEN IDEC INC 3.4% 2.8% 2.8%
ALNYLAM PHARMACEUTICALS INC 4.0% 1.0% 1.0%

Position Highlights (Non-Overlapping Exposures)
MEDX Overweight Relative to GDOC
ELI LILLY & CO 6.6%
NOVARTIS AG-ADR 6.1%
ASTRAZENECA PLC-SPONS ADR 5.8%
BRISTOL-MYERS SQUIBB CO 4.7%
REGENERON PHARMACEUTICALS 4.5%
JOHNSON & JOHNSON 4.5%
MERCK & CO. INC. 4.2%
PFIZER INC 4.0%
ALKERMES PLC 3.4%
ABBVIE INC 3.3%
MEDX Underweight Relative to GDOC
ASTRAZENECA PLC -6.2%
BOSTON SCIENTIFIC CORP -5.9%
NOVO NORDISK A/S-B -5.8%
INTUITIVE SURGICAL INC -5.0%
DANAHER CORP -3.8%
METTLER-TOLEDO INTERNATIONAL -3.4%
NEUROCRINE BIOSCIENCES INC -3.4%
HUMANA INC -3.4%
INSULET CORP -3.4%
COOPER COS INC/THE -3.3%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY